As of 2025-07-09, the Intrinsic Value of International Biotechnology Trust PLC (IBT.L) is 420.13 GBP. This IBT.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 598.00 GBP, the upside of International Biotechnology Trust PLC is -29.70%.
The range of the Intrinsic Value is 320.87 - 596.64 GBP
Based on its market price of 598.00 GBP and our intrinsic valuation, International Biotechnology Trust PLC (IBT.L) is overvalued by 29.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 320.87 - 596.64 | 420.13 | -29.7% |
| DCF (Growth 10y) | 348.52 - 598.29 | 439.53 | -26.5% |
| DCF (EBITDA 5y) | 215.24 - 363.04 | 288.61 | -51.7% |
| DCF (EBITDA 10y) | 276.96 - 421.66 | 345.43 | -42.2% |
| Fair Value | 1,305.47 - 1,305.47 | 1,305.47 | 118.31% |
| P/E | 323.70 - 623.49 | 482.83 | -19.3% |
| EV/EBITDA | 223.32 - 517.40 | 407.63 | -31.8% |
| EPV | 191.10 - 270.68 | 230.89 | -61.4% |
| DDM - Stable | 341.17 - 780.24 | 560.71 | -6.2% |
| DDM - Multi | 324.49 - 543.63 | 403.60 | -32.5% |
| Market Cap (mil) | 201.29 |
| Beta | 0.23 |
| Outstanding shares (mil) | 0.34 |
| Enterprise Value (mil) | 232.78 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.37% |
| Cost of Debt | 5.20% |
| WACC | 9.83% |